Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million by 2025

 The global Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million and is anticipated to grow at a CAGR of 3.2% in the years to come. Xerostomia is a clinical condition of dry mouth and does not show the signs of hyposalivation and symptoms on frequent terms. This condition is observed when the rate of saliva flow is low in comparison with absorption across the oral mucosa coupled with rate of fluid evaporation from the mouth.


Prolonged xerostomia is a significant disease in patients since it affects speech, chewing, denture-wearing, and swallowing activities. The defined causes of hyposalivation and xerostomia are the use of several medications such as antidepressants, anticoagulants, antiretroviral, hypoglycemics, multivitamins and supplements, and anti-inflammatory drugs. Prevalence of xerostomia persists in a large population with different age groups despite following medical or dental consultation.


Rise in use of prescribed medication coupled with rising prevalence of HIV and cancer are expected to act as primary drivers for market growth. Secondary factors such as easy availability of cost-effective medications along with rise in preference for prescription drugs act as market drivers. 


Download Free sample Report https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market/request-sample


 In addition, rising cases of depression, Parkinson’s disease, HIV, and hypertension are also expected to contribute significantly to the market development. The market is further triggered by rise in cases of chronic xerostomia due to intake of certain medications. However, significant costs and uneven medical infrastructure arelikely to hinder the market growth in the forecast period upto 2025.


Xerostomia (Dry mouth) therapeutics market is segmented into type, product, and region. Type category includes prescription and OTC. “Over-the-counter (OTC)” segment accounts for a larger share and is expected to gain significant momentum in the forecast period owing to wide variety & availability of branded drugs and low-cost products. Product segmentation includes salivary substitutes, salivary stimulants, and dentrifices. Dentrifices segment accounted for a significant market share owing to effectiveness, affordability and higher adoption.Geographic segmentation for xerostomia (dry mouth) therapeutics industry includes North America, South America, Europe, Asia-Pacific, Middle East and Africa.


Asia-Pacific’s xerostomia therapeutics market is anticipated to rise at a CAGR of 4.2% in the forthcoming period due to rising awareness, high prevalence of Parkinson’s disease, cancer and HIV. North America followed by Europe accounts for a higher revenue share owing to rising prevalence of xerostomia and other dry mouth diseases such as rheumatoid arthritis, Sjogren’s syndrome and HIV along with rising awareness by government and health care NGOs.


The key players in the xerostomia (dry mouth) therapeutics market include GlaxoSmithKline plc; Church & Dwight Co., Inc.; Colgate-Palmolive Company; Hikma Pharmaceuticals PLC; Pendopharm; Sun Pharmaceuticals Industries Ltd.; Lupin Pharmaceuticals, Inc.; Pfizer, Inc.; Parnell Pharmaceuticals, Inc.; Acacia Pharma; and OraCoat.


Market Segment:


Type Outlook (Market Revenue in USD Million, 2014 - 2025)

    • OTC

    • Prescription


Browse Full Research Report with TOC:  

https://www.millioninsights.com/industry-reports/xerostomia-dry-mouth-therapeutics-market


Product Outlook (Market Revenue in USD Million, 2014 - 2025)

    • Salivary Stimulants

    • Salivary Substitutes

    • Dentifrices


Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

        • U.S.

        • Canada

    • Europe

        • Germany

        • UK

    • Asia Pacific

        • China

        • Japan

        • India

    • Latin America

        • Brazil

        • Mexico

    • Middle East & Africa

        • South Africa

continue........


Get In Touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person: 

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com


Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com


Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Comments

Post a Comment

Popular posts from this blog

Global and Chinese Bufexamac Market Outlook and Analysis 2019 to 2022

15-mar-2019 The Bufexamac Market 2017 Report offers detailed analysis of the Bufexamac market over the last five years, and provides extensive market forecasts by region/country and sub sector. It covers the key technological and market trends in the Bufexamac market. It further lays out an analysis of the factors influencing the supply/demand for Bufexamac, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. In particular, it provides an in-depth analysis of the following: Market overview: detailed analysis of the whole value chain (upstream & downstream), insights into technological developments, and an extensive analysis of costs analysis from the aspects of raw materials, labor costs and etc. Market size and driving factors: comprehensive analysis of the global Bufexamac market
Read more

Global Diabetes Care Products Market Study 2016-2022

14-mar-2019 In this report, the global Diabetes Care Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Care Products for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Diabetes Care Products market competition by top manufacturers/players, with Diabetes Care Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including BD Bayer Abbott B. Braun Medtronic Tandem Diabetes Care Insulet Corporation Roche J&J ARKRAY Inc Ypsomed Sannuo Sanofi On the basis of product, this report displays the production, revenue, price, market share and growth rate of each
Read more

Antidiabetic Biguanides Market Survey - Global Industry Share, Size, Trends and Forecasts, 2017

This report studies sales (consumption) of Antidiabetic Biguanides in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering • Anderson Hay & Grain Inc. • Border Valley • Sanofi • Takeda Pharmaceuticals • Eli Lilly • Merck & Co. • Novo Nordisk Request a Sample Copy of This Report:  https://www.radiantinsights.com/research/global-antidiabetic-biguanides-sales-market-report-2017/request-sample Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antidiabetic Biguanides in these regions, from 2011 to 2021 (forecast), like • United States • China • Europe • Japan • Southeast Asia • India Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of
Read more